COVID-19 continues to ravage the world over a year after it was declared a pandemic.
As new variants prop up and vaccine inequalities worsen, whatever modest gains the world has made against the virus are under risk of being lost.
Unless, that is, vaccine production is ramped up to ensure enough doses for one and all.
The current global vaccine manufacturing capacity is just not sufficient to inoculate humanity against the virus anytime soon. At the current pace, international herd immunity may take as late as 2024 to be achieved.
What are the supply crunches affecting vaccine production? And how can India - aka the "pharmacy of the world" - boost its vaccine manufacturing prowess in the near-term?
Click link for a deep-dive: https://transfin.in/covid-19-vaccine-production-in-india-challenges-opportunities-and-solutions
The COVID-19 pandemic has caused more than 600,000 deaths in the United States since the start of 2020 and more than 4 million globally.
RNA is a type of genetic code that can be translated into proteins that allow the virus to replicate.
During its RNA duplication, the virus would typically have a distinct chemical genetic signature -; a string of molecules, or bases, that appends to one end of SARS-CoV-2's RNA backbone.This chemical signature would normally be recognizable by the body and produce an immune response, but the virus has a special way of hiding the extra molecules and sneaking into the body undetected.
The research team used the resources of the Advanced Photon Source (APS), a DOE Office of Science User Facility at Argonne, to test a new treatment option that may foil this mechanism.The research was led by Andrzej Joachimiak of Argonne and the University of Chicago, with Argonne protein crystallographer Youngchang Kim and University of Chicago structural biologist Natalia Maltseva and their colleagues.
Joachimiak is the director of the Structural Biology Center (SBC) at the APS, and the research team used the high-powered X-ray beams generated there to study one of the virus's proteins, called Nsp15.This protein acts like a molecular scissors, cutting regions of the virus that are involved in its ability to make copies of itself.
As more and more of those strings of molecules -; made up of uridine, one of the main components of nucleic acid -; are produced, the Nsp15 molecule removes them, essentially giving the virus the haircut it needs to pass undetected undercover.
At Medical PPE Resource, we care about the health of our community.
This test helps to find the IgG antibody to SARS-CoV-2.
The IgG antibody test is intended for the qualitative detection of IgG-class antibodies against COVID-19.
A positive IgG result indicates the previous infection with COVID-19.
A negative test result ensures that the antibodies to the virus that causes COVID-19 were not found in your sample.
This test is designed to detect antibodies up against the virus that causes COVID-19.
Metropolis has been approved by the Govt to collect samples for COVID 19 Test.
And to assure that nothing comes between this fight against COVID 19 pandemic, we are well equipped with kits for Corona Test.
Our phlebotomists are always on the move so that your sample can be collected for SARS CoV 2 Test in the comfort of your home.
Get accurate and quick reports done at a cost within 24 to 48 hours.
To book a home visit for Coronavirus Tests, Call 8422‑801‑801 (Maharashtra), 044‑4292‑5555 (Chennai), 011‑4228‑0666 (Delhi) to book a testhttps://www.metropolisindia.com/covid-19-test/COVID 19 testCorona TestCorona Virus Test CentresCOVID 19 Testing Centers Coronavirus TestsSARS CoV 2 Test
Corona-viruses are a large family of viruses that are known to cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome(SARS).What is SARS-CoV-2?
SARS-CoV-2 is a new strain of corona-virus that has not been previously identified in humans.Where do corona-viruses come from?Corona-viruses are viruses that circulate among animals with some of them also known to infect humans.Bats are considered as natural hosts of these viruses yet several other species of animals are also known to be a source.
More information on corona-viruses can be found on the ECDC fact-sheet.Is this virus comparable to SARS or to the seasonal flu?The novel corona-virus detected in China is genetically closely related to the SARS-CoV-1 virus.
SARS emerged at the end of 2002 in China, and it caused more than 8 000 cases in 33 countries over a period of eight months.
The current COVID-19 outbreak caused around 7 000 reported cases in China during the first month after initial reports (January 2020), with a further 80 000 cases reported globally during the second month (February 2020).
While the viruses that cause both COVID-19 and seasonal influenza are transmitted from person-to-person and may cause similar symptoms, the two viruses are very different and do not behave in the same way.
